Washington, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Missouri voters passed Amendment 2 legalizing medical cannabis in the state. New Frontier Data, the authority in data, analytics and business intelligence on the global cannabis industry, projects Missouri’s annual sales of medical cannabis to reach $111 million, with an estimated 2,800 cannabis-related jobs created in the state by 2025. Amendment 2 amends the state constitution to permit doctors to prescribe cannabis, which would be taxed at 4%, and allow for home cultivation.

“Missouri’s decision to legalize is congruent with shifting national opinions on cannabis, with more than 66% of Americans now in favor of full legalization,” said Giadha Aguirre de Carcer, Founder and CEO of New Frontier Data. “As we reported in our recently-published report The U.S. Cannabis Report: 2018 Industry Outlook, U.S. legal cannabis sales are projected to grow to more than $25 billion by 2025, creating vast opportunities for revenue and job growth throughout the country.”

Missouri is now among the 34 states to legalize medical cannabis in the United States.

About New Frontier Data:
New Frontier Data is an independent, technology-driven analytics company specializing in the cannabis industry. It offers vetted data, actionable business intelligence and risk management solutions for investors, operators, researchers and policymakers. New Frontier Data’s reports and data have been cited in over 69 countries around the world to inform industry leaders. Founded in 2014, New Frontier Data is headquartered in Washington, D.C. with additional offices in Denver, CO, London, UK, Bogota, Colombia, and Hong Kong. 

New Frontier Data does not take a position on the merits of cannabis legalization. Rather, its mission and mandate are to inform cannabis-related policy and business decisions through rigorous, issue-neutral and comprehensive analysis of the legal cannabis industry worldwide. For more information about New Frontier Data please visit: http://www.NewFrontierData.com.